Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial)
Version 2 2024-06-06, 01:28Version 2 2024-06-06, 01:28
Version 1 2023-06-15, 06:01Version 1 2023-06-15, 06:01
journal contribution
posted on 2024-06-06, 01:28authored byMS Sousa, Peter MartinPeter Martin, MJ Johnson, M Lind, M Maddocks, A Bullock, M Agar, S Chang, S Kochovska, I Kinchin, D Morgan, B Fazekas, V Razmovski-Naumovski, JT Lee, M Itchins, V Bray, DC Currow
Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial)